Medicare has lowered its star ratings for staffing levels in 1 out of 11 nursing homes; the Pharmaceutical Research and Manufacturers of America has donated to a lobbying group running a "dark money" campaign in favor of repealing and replacing the Affordable Care Act; a libertarian policy center funded by the conservative Koch brothers found that Senator Bernie Sanders's Medicare for All plan would cost $32.6 trillion over 10 years.
Medicare has lowered its star ratings for staffing levels in 1 out of 11 nursing homes—about 1400 of them—because they were either inadequately staffed with registered nurses or failed to provide payroll data that proved they had the required nursing coverage, The New York Times reported. Medicare’s 5-star rating system is a tool for families searching for nursing homes, and the rankings are published on the government’s Nursing Home Compare website. Medicare only recently began collecting and publishing payroll data on the staffing of nursing homes as required by the Affordable Care Act (ACA) of 2010. Before 2010, the government relied on the nursing homes’ own unverified reports.
The Pharmaceutical Research and Manufacturers of America, better known as PhRMA, is funding a lobbying group running a dark money campaign in favor of repealing and replacing the ACA, Kaiser Health News reported. PhRMA was in favor of the ACA in 2010, but has now contributed $6.1 million to the American Action Network, which is closely associated with House Republicans, who have been trying to do away with the landmark health law.
A libertarian policy center funded by the conservative Koch brothers found that Senator Bernie Sanders's Medicare for All plan would cost $32.6 trillion over 10 years, according to The Associated Press. Sanders, and independent from Vermont, wants Medicare to cover all residents with no deductibles and or copays for medical services. The analysis, released by the Mercatus Center at George Mason University in Virginia, said the plan would deliver significant savings on administration and drug costs, but increased demand for care would drive up spending, the analysis found.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More